Dr. Hugh Calkins answers the question: 'Atrial Fibrillation vs. Atrial Flutter?' — -- Question: My doctor told me I sometimes have atrial fibrillation and at other times have atrial flutter. What ...

There is conflicting evidence regarding bisphosphonates and atrial fibrillation (AF) risk in osteoporosis patients. However, bisphosphonates are used in much higher doses in treatment of bone ...

Please provide your email address to receive an email when new articles are posted on . Atrial flutter catheter ablation in patients without a history of atrial fibrillation reduced risk for death, ...

Bisphosphonates are an effective treatment for osteoporosis, but several trials reported an association between use of these drugs and an increased risk of atrial fibrillation and flutter; other ...

Please provide your email address to receive an email when new articles are posted on . Tempus announced the FDA has granted a breakthrough device designation to its ECG analysis platform for the ...

RESTORE SR to study efficacy and safety of vanoxerine in atrial fibrillation (AF) and atrial flutter (AFL) patients, results expected in the second half of 2016 LA JOLLA, Calif., Laguna ...

Q: I’m a 67-year-old man who developed typical atrial flutter two years ago, but I haven’t had any symptoms that I am aware of. I don’t have a history of heart problems. My heart rate was 117 bpm ...

AMSTERDAM -- Reducing atrial pacing didn't help prevent atrial fibrillation (Afib, or AF) in patients with sinus node dysfunction but did increase risk of fainting, the DANPACE II trial showed. The ...

Forty-five per cent of patients admitted to hospital for atrial fibrillation (AF) in Australia and New Zealand die within a decade, according to University of Queensland research. A team led by Dr.